Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Deep Vein Thrombosis/Acute Pulmonary Embolism Treatment
Dose: Subcutaneous injection – 5 mg
Frequency: once daily
Duration: for 5-9 days; up to 26 days administered in clinical trials
Indication: Deep Vein Thrombosis/Acute Pulmonary Embolism Treatment
Dose: Subcutaneous injection – 7.5 mg
Frequency: once daily
Duration: for 5-9 days; up to 26 days administered in clinical trials

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Not specified – Safety and efficacy not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment (Creatinine Clearance less than 20 milliliters per minute)
Dose: Contraindicated
Note: Contraindicated
Condition: Renal impairment (Creatinine Clearance 20-50 milliliters per minute)
Dose: 1.5 mg
Frequency: once daily
Administration
  • Give SC injection 6-8 hours after surgery
  • Inject in abdomen area
Side Effect

Drug Interaction

Drug NameRisk Factors
Desirudin, Fibrinolytic Drugs (Streptokinase, Alteplase), Glycoprotein IIb/IIIa-receptor antagonists, Heparin, Heparinoids, LMWH
Increased risk of bleeding

Disease Interaction

Disease NameRisk Factors
Active Bleeding
Risk of severe hemorrhage
Bacterial Endocarditis
Risk of complications

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 25° C. Do not freeze.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.